Phil Hyu Lee Selected Research

5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)

4/2021	Relationship between Hearing Loss and Dementia Differs According to the Underlying Mechanism.
1/2021	Implication of Small Vessel Disease MRI Markers in Alzheimer's Disease and Lewy Body Disease.
1/2021	Structural connectivity networks in Alzheimer's disease and Lewy body disease.
1/2021	Association of Dipeptidyl Peptidase-4 Inhibitor Use and Amyloid Burden in Patients With Diabetes and AD-Related Cognitive Impairment.
1/2020	Neural Correlates of Cognitive Performance in Alzheimer's Disease- and Lewy Bodies-Related Cognitive Impairment.
7/2019	Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
1/2019	Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction.
10/2018	Olfactory dysfunction in Alzheimer's disease- and Lewy body-related cognitive impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Phil Hyu Lee Research Topics

Disease

82	Parkinson Disease (Parkinson's Disease) 06/2022 - 03/2006
28	Dementia (Dementias) 03/2022 - 12/2008
24	Cognitive Dysfunction 03/2022 - 12/2008
22	Dyskinesias (Dyskinesia) 06/2022 - 10/2010
20	Parkinsonian Disorders (Parkinsonism) 01/2021 - 03/2006
18	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 12/2009
13	Multiple System Atrophy 01/2021 - 03/2006
10	Synucleinopathies 10/2021 - 03/2009
6	Atrophy 01/2022 - 01/2014
6	Disease Progression 11/2021 - 01/2011
6	Ischemic Stroke 01/2016 - 06/2005
6	Stroke (Strokes) 06/2010 - 04/2005
5	Lewy Body Disease (Lewy Body Dementia) 01/2022 - 01/2020
5	Cerebral Cortical Thinning 01/2020 - 01/2013
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 03/2009
4	Movement Disorders (Movement Disorder) 01/2016 - 05/2008
3	Tremor (Tremors) 01/2016 - 08/2006
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2009 - 04/2005
2	Genetic Risk Score 05/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 01/2017
2	Body Weight (Weight, Body) 11/2021 - 01/2021
2	Autonomic Nervous System Diseases (Dysautonomia) 01/2021 - 08/2020
2	Hypertension (High Blood Pressure) 11/2019 - 04/2009
2	Task-Specific Focal Dystonia 01/2019 - 12/2016
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2018 - 01/2015
2	Emergence Delirium 01/2018 - 02/2013
2	Frontotemporal Dementia (Semantic Dementia) 01/2018 - 12/2009
2	Gaucher Disease (Gaucher's Disease) 04/2012 - 06/2011
2	Pain (Aches) 03/2012 - 06/2011
2	Neuroblastoma 03/2010 - 06/2006
2	Brain Ischemia (Cerebral Ischemia) 04/2009 - 06/2006
2	Inflammation (Inflammations) 01/2009 - 07/2007
1	Nervous System Diseases (Neurological Disorders) 11/2021
1	Sarcopenia 11/2021
1	Spinal Diseases (Disease, Spinal) 03/2021
1	Anosmia 01/2021
1	Hypokinesia (Bradykinesia) 01/2021
1	Neuroinflammatory Diseases 07/2020
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Neoplasms (Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

30	Levodopa (L Dopa)FDA LinkGeneric 06/2022 - 11/2009
27	Pharmaceutical PreparationsIBA 06/2022 - 03/2006
26	Dopamine (Intropin)FDA LinkGeneric 03/2022 - 05/2014
21	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 03/2022 - 11/2013
13	Amyloid (Amyloid Fibrils)IBA 03/2022 - 03/2012
12	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2017
10	SynucleinsIBA 10/2021 - 02/2013
8	5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA 04/2021 - 10/2018
5	Cholinergic Agents (Cholinergics)IBA 01/2022 - 03/2012
5	Neuroprotective AgentsIBA 11/2021 - 11/2009
5	Uric Acid (Urate)IBA 10/2021 - 07/2011
4	Glucosylceramidase (Glucocerebrosidase)IBA 01/2021 - 06/2011
4	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2021 - 05/2014
4	alpha-SynucleinIBA 01/2018 - 03/2009
4	3-Iodobenzylguanidine (Iobenguane)IBA 11/2007 - 03/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2006
3	HomocysteineIBA 10/2014 - 03/2010
2	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2017
2	CholesterolIBA 11/2021 - 04/2009
2	Apolipoprotein E4IBA 10/2021 - 10/2021
2	Apolipoproteins E (ApoE)IBA 10/2021 - 01/2013
2	Memantine (Namenda)FDA Link 10/2021 - 05/2015
2	Cerebroside-Sulfatase (Arylsulfatase A)IBA 01/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2014
2	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 01/2015
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 10/2014 - 01/2011
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 08/2014 - 11/2009
2	AcidsIBA 07/2014 - 09/2009
2	C-Reactive ProteinIBA 02/2009 - 04/2005
2	LipopolysaccharidesIBA 01/2009 - 07/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2021
1	Indicators and Reagents (Reagents)IBA 11/2021
1	AntioxidantsIBA 10/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	valrubicin (AD 32)FDA Link 01/2021
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2021
1	Donepezil (Aricept)FDA LinkGeneric 01/2021
1	Amyloid beta-PeptidesIBA 01/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021
1	Therapeutic UsesIBA 01/2020
1	Pioglitazone (Actos)FDA Link 01/2019
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2019
1	Dopamine Agonists (Dopamine Agonist)IBA 10/2018
1	Leucine (L-Leucine)FDA Link 02/2017
1	Phosphotransferases (Kinase)IBA 02/2017
1	tau Proteins (tau Protein)IBA 01/2017

Therapy/Procedure

10	Therapeutics 01/2021 - 06/2005
4	Transplantation 01/2015 - 06/2005
3	Mesenchymal Stem Cell Transplantation 06/2010 - 06/2005
2	Secondary Prevention 11/2021 - 02/2008
2	Gastrectomy 01/2019 - 02/2013
2	Activities of Daily Living (ADL) 01/2017 - 03/2012
2	Deep Brain Stimulation 03/2012 - 10/2010
1	Postoperative Care 03/2021
1	Aftercare (After-Treatment) 10/2018
1	Pallidotomy 08/2018